• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参皂苷 Rg3 通过表观遗传调控 ACSL4 促进肝星状细胞铁死亡,抑制肝纤维化进展。

Ginsenoside Rg3 promotes hepatic stellate cell ferroptosis by epigenetically regulating ACSL4 to suppress liver fibrosis progression.

机构信息

Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou 325000, Zhejiang, PR China; Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo 315300, Zhejiang, PR China.

Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, No.2 Fuxue Lane, Wenzhou 325000, Zhejiang, PR China.

出版信息

Phytomedicine. 2024 Feb;124:155289. doi: 10.1016/j.phymed.2023.155289. Epub 2023 Dec 16.

DOI:10.1016/j.phymed.2023.155289
PMID:38176269
Abstract

BACKGROUND

Ginsenoside Rg3 (G-Rg3), extracted from Panax notoginseng, possesses hepatoprotective properties. Hepatic stellate cells (HSCs) activation is responsible for liver fibrosis. Recent studies have reported the suppressive effects of G-Rg3 on HSC activation and proliferation. Ferroptosis is a novel iron regulated cell death. ACSL4, a key indicator of ferroptosis, is commonly methylated in various diseases.

PURPOSE

However, the role of ACSL4 methylation-mediated HSC ferroptosis in G-Rg3 inhibition of hepatic fibrosis needs to be explored.

METHODS

Effects of G-Rg3 on inhibiting fibrosis were evaluated in vivo and in vitro. The impact of G-Rg3 on HSC ferroptosis was assessed in vitro. Furthermore, the expression of ACSL4, ACSL4 methylation and microRNA-6945-3p (miR-6945-3p) levels were determined.

RESULTS

G-Rg3 significantly alleviated CCl-induced liver fibrosis, accompanied by collagen downregulation. In vitro, G-Rg3 contributed to HSC inactivation, leading to decreased collagen production. G-Rg3 induced HSC ferroptosis, characterized by increased iron accumulation, depletion of glutathione, malondialdehyde levels, and generation of lipid reactive oxygen species. Moreover, G-Rg3 promoted ACSL4 demethylation and restored its expression. Notably, DNMT3B counteracted the effect of G-Rg3-mediated inhibition of ACSL4 methylation and was targeted by miR-6945-3p. Further investigations revealed that G-Rg3 suppressed ACSL4 methylation through miR-6945-3p-mediated DNMT3B inhibition. Consistent with this, miR-6945-3p inhibition reversed G-Rg3-induced ACSL4 expression and HSC ferroptosis.

CONCLUSION

G-Rg3 inhibits ACSL4 methylation by miR-6945-3p-mediated DNMT3B inhibition, thereby promoting HSC ferroptosis and mitigating liver fibrosis.

摘要

背景

从三七中提取的人参皂苷 Rg3(G-Rg3)具有保肝作用。肝星状细胞(HSCs)激活是肝纤维化的原因。最近的研究报告称,G-Rg3 对 HSC 激活和增殖具有抑制作用。铁死亡是一种新型的铁调节细胞死亡。酰基辅酶 A 合成酶家族成员 4(ACSL4)是铁死亡的一个关键指标,在各种疾病中通常被甲基化。

目的

然而,ACSL4 甲基化介导的 HSC 铁死亡在 G-Rg3 抑制肝纤维化中的作用需要进一步探讨。

方法

在体内和体外评估 G-Rg3 抑制纤维化的效果。在体外评估 G-Rg3 对 HSC 铁死亡的影响。此外,测定 ACSL4、ACSL4 甲基化和 microRNA-6945-3p(miR-6945-3p)的表达水平。

结果

G-Rg3 显著减轻 CCl4 诱导的肝纤维化,同时下调胶原表达。体外,G-Rg3 促进 HSC 失活,导致胶原产生减少。G-Rg3 诱导 HSC 铁死亡,表现为铁积累增加、谷胱甘肽耗竭、丙二醛水平升高和脂质活性氧生成。此外,G-Rg3 促进 ACSL4 去甲基化并恢复其表达。值得注意的是,DNMT3B 抵消了 G-Rg3 介导的 ACSL4 甲基化抑制作用,并且是 miR-6945-3p 的靶标。进一步研究表明,G-Rg3 通过 miR-6945-3p 介导的 DNMT3B 抑制抑制 ACSL4 甲基化。与此一致,miR-6945-3p 抑制逆转了 G-Rg3 诱导的 ACSL4 表达和 HSC 铁死亡。

结论

G-Rg3 通过 miR-6945-3p 介导的 DNMT3B 抑制抑制 ACSL4 甲基化,从而促进 HSC 铁死亡和减轻肝纤维化。

相似文献

1
Ginsenoside Rg3 promotes hepatic stellate cell ferroptosis by epigenetically regulating ACSL4 to suppress liver fibrosis progression.人参皂苷 Rg3 通过表观遗传调控 ACSL4 促进肝星状细胞铁死亡,抑制肝纤维化进展。
Phytomedicine. 2024 Feb;124:155289. doi: 10.1016/j.phymed.2023.155289. Epub 2023 Dec 16.
2
Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11.人参皂苷 Rh2 通过调节 IRF1 抑制的 SLC7A11 促进肝星状细胞铁死亡和失活。
Phytomedicine. 2023 Sep;118:154950. doi: 10.1016/j.phymed.2023.154950. Epub 2023 Jul 4.
3
Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.人参皂苷20(S)-Rg3通过调控DNMT3A/miR-532-3p/HK2通路抑制卵巢癌细胞的瓦伯格效应。
Cell Physiol Biochem. 2018;45(6):2548-2559. doi: 10.1159/000488273. Epub 2018 Mar 16.
4
Ginsenoside Rb1 induces hepatic stellate cell ferroptosis to alleviate liver fibrosis via the BECN1/SLC7A11 axis.人参皂苷Rb1通过BECN1/SLC7A11轴诱导肝星状细胞铁死亡以减轻肝纤维化。
J Pharm Anal. 2024 May;14(5):100902. doi: 10.1016/j.jpha.2023.11.009. Epub 2023 Nov 29.
5
Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway.人参皂苷 Rg3 通过减少炎症介导的自噬信号通路促进肝纤维化逆转。
Cell Death Dis. 2020 Jun 12;11(6):454. doi: 10.1038/s41419-020-2597-7.
6
miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-β.miR-301a-3p 通过调控 PTEN/PDGFR-β 促进肝星状细胞激活和肝纤维化。
Int Immunopharmacol. 2022 Sep;110:109034. doi: 10.1016/j.intimp.2022.109034. Epub 2022 Jul 11.
7
Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.铁蛋白自噬的激活对于 RNA 结合蛋白 ELAVL1/HuR 调控肝星状细胞中的铁死亡是必需的。
Autophagy. 2018;14(12):2083-2103. doi: 10.1080/15548627.2018.1503146. Epub 2018 Aug 21.
8
miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.miR-140-3p基因敲低通过PTEN介导的AKT/mTOR信号通路抑制肝星状细胞的增殖和纤维化。
Yonsei Med J. 2019 Jun;60(6):561-569. doi: 10.3349/ymj.2019.60.6.561.
9
Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.镁甘氨酸甘草酸盐通过调节铁死亡信号通路改善肝纤维化和肝星状细胞激活。
Biomed Pharmacother. 2018 Oct;106:125-133. doi: 10.1016/j.biopha.2018.06.060. Epub 2018 Jun 26.
10
MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression.微小 RNA-195-3p 通过抑制 PTEN 表达促进肝星状细胞活化和肝纤维化。
Toxicol Lett. 2022 Feb 1;355:88-99. doi: 10.1016/j.toxlet.2021.11.014. Epub 2021 Nov 25.

引用本文的文献

1
Maimendong decoction and its active ingredient, ophiopogonin D, alleviate bleomycin-induced pulmonary fibrosis by regulating the behavior of lung fibroblasts.麦冬汤及其活性成分麦冬皂苷D通过调节肺成纤维细胞的行为来减轻博来霉素诱导的肺纤维化。
Chin Med. 2025 Aug 29;20(1):135. doi: 10.1186/s13020-025-01206-x.
2
Notoginsenoside R2 attenuates hepatic fibrosis via STAT3-dependent hepatic stellate cells senescence induction and inflammatory microenvironment suppression.三七皂苷R2通过依赖STAT3诱导肝星状细胞衰老和抑制炎症微环境来减轻肝纤维化。
J Ginseng Res. 2025 Sep;49(5):574-584. doi: 10.1016/j.jgr.2025.05.007. Epub 2025 May 30.
3
Ferroptosis and gut microbiota: A new horizon in alcohol-associated liver disease management.
铁死亡与肠道微生物群:酒精性肝病管理的新视野。
Cell Mol Life Sci. 2025 Jul 19;82(1):282. doi: 10.1007/s00018-025-05815-5.
4
Integrated multi‑omics analysis of liver metabolic dysregulation in ACE2 knockout mice.ACE2基因敲除小鼠肝脏代谢失调的综合多组学分析
Int J Mol Med. 2025 Sep;56(3). doi: 10.3892/ijmm.2025.5575. Epub 2025 Jul 4.
5
Molecular mechanisms behind the inhibitory effects of ginsenoside Rg3 on hepatic fibrosis: a review.人参皂苷Rg3对肝纤维化抑制作用的分子机制综述
Arch Toxicol. 2025 Feb;99(2):541-561. doi: 10.1007/s00204-024-03941-w. Epub 2024 Dec 27.
6
The role of ferroptosis-related non-coding RNA in liver fibrosis.铁死亡相关非编码RNA在肝纤维化中的作用
Front Cell Dev Biol. 2024 Dec 9;12:1517401. doi: 10.3389/fcell.2024.1517401. eCollection 2024.
7
Quercetin alleviates liver fibrosis via regulating glycolysis of liver sinusoidal endothelial cells and neutrophil infiltration.槲皮素通过调节肝窦内皮细胞糖酵解和中性粒细胞浸润缓解肝纤维化。
Biomol Biomed. 2024 Oct 17;24(6):1806-1815. doi: 10.17305/bb.2024.10530.
8
Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion-induced ferroptosis via the keap1/Nrf2/GPX4 signaling pathway.人参皂苷 Rg3 通过 Keap1/Nrf2/GPX4 信号通路减轻心肌缺血/再灌注诱导的铁死亡。
BMC Complement Med Ther. 2024 Jun 26;24(1):247. doi: 10.1186/s12906-024-04492-4.